Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Arizona

Arizona Oncology Associates, PC
Phoenix Arizona 85016

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

California

Samuel Oschin Cancer Center
Los Angeles California 90048

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Sarcoma Oncology Center
Santa Monica California 940403

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Sarcoma Oncology Center
Santa Monica California 90403

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Stanford University Medical Center
Stanford California 94305

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Florida

Mayo Clinic Jacksonville
Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Moffitt Cancer Center
Tampa Florida 33612

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Georgia

Georgia Cancer Specialists
Atlanta Georgia 30341

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Emory University
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Illinois

Northwestern Medical Faculty Foundation
Chicago Illinois 60611

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Edward Cancer Center
Naperville Illinois 60540

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Oncology Specialists, SC
Niles Illinois 60714

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Iowa

University of Iowa Hospitals and Clinics
Iowa City Iowa 52242

A clinical trial to evaluate treatments using Bevacizumab, Gemcitabine, docetaxel and valproic acid for patients

University of Iowa Hospitals & Clinics
Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Maryland

University of Maryland
Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Michigan

University of Michigan
Ann Arbor Michigan 48109

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

University of Michigan
Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Nebraska

Nebraska Methodist Hospital
Omaha Nebraska 68114

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

New York

Mount Sinai School of Medicine-Tisch Cancer Institute
New York New York 10029

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

North Carolina

Levine Cancer Institute
Charlotte North Carolina 28204

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Duke University
Durham North Carolina 27710

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Oregon

Center for Health and Healing
Portland Oregon 97239

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Pennsylvania

U of Pittsburgh Cancer Institute
Pittsburgh Pennsylvania 15232

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

South Carolina

Medical University of South Carolina Hollings Cancer Center
Charleston South Carolina 29425

Patients are needed to participate in a clinical research study of Panobinostat (LBH589), Sorafenib to evaluate Renal Cancer or Non Small Cell Lung Cancer (NSCLC)

Tennessee

Vanderbilt University
Nashville Tennessee 37212

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Texas

University of Texas MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Vermont

Fletcher Allen Health Care
Burlington Vermont 05401

A Phase 1/Phase 2 clinical study for patients with Operable Soft Tissue Sarcoma

Fletcher Allen Health Care
Burlington Vermont 05405

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Wisconsin

Medical College of Wisconsin
Milwaukee Wisconsin 53226

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Australia

Peter MacCallum Cancer Centre
Melbourne Victoria 3002

A clinical trial to evaluate treatments using Sunitinib malate and Radiotherapy for patients with Soft Tissue Sarcoma

Canada

McGill University
Montreal Quebec H2W156

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

France

Institut Bergonie
Bordeaux Cedex Aquitaine

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Centre Georges Francois Leclerc
Dijon Bourgogne

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Centre Leon Berard
Lyon Rhone-Alpes

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Hopital Rene Huguenin - Institut Curie
Saint-Cloud Ile-de-France

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Institut de Cancérologie Gustave Roussy
Villejuif 94805

A clinical trial to evaluate treatments using NGR-hTNF and Doxorubicin for patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Germany

Department of Oncology, Hematology and Palliative Medicine, Marien Hospital Düsseldorf
Düsseldorf Nordrhein-Westfalen D-40479

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Department of Hematology, Hemostaseology, Oncology and Stemm Cell Transplantation, Medical School Hannover
Hannover Niedersachen D-30625

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Comprehensive Cancer Center North, University Hospital Kiel
Kiel 24105

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Sarcoma Center Mannheim, University Hospital Mannheim
Mannheim 68167

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Center for Soft Tissue Sarcoma, University Hospital Tübingen
Tübingen 72074

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

View More »

Department of Hematology, Oncology, Rheumatology and Immunology, University Hospital Tübingen
Tübingen Baden-Württemberg D-72076

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Comprehensive Cancer Center Ulm (CCCU)
Ulm 89081

Patients are needed to participate in a clinical research study of Vorinostat to evaluate Soft Tissue Sarcoma

Hungary

Magyar Honvedseg Egeszsegugyi Kozpont
Budapest

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Italy

Istituto Ortopedico Rizzoli
Bologna 40136

A clinical trial to evaluate treatments using NGR-hTNF and Doxorubicin for patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Fondazione del Piemonte per l'Oncologia
Candiolo Torino

A Phase 3 clinical study for patients with Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

First 1 2 Last